Evidence map›Paper›PMID 29632827›Full record

ArticleBiochimie open2015

Proline substitutions in a Mip-like peptidyl-prolyl

Soumitra Polley, Devlina Chakravarty, Gopal Chakrabarti, Rajagopal Chattopadhyaya, Subrata Sau

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biochimie open, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Identification of Substrates of Cytoplasmic Peptidyl-ProlylInternational journal of molecular sciences · 2020
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Soumitra PolleyDepartment of Biochemistry, Bose Institute, P-1/12, CIT Scheme VII M, Kolkata 700054, West Bengal, India.
Devlina ChakravartyDepartment of Biochemistry, Bose Institute, P-1/12, CIT Scheme VII M, Kolkata 700054, West Bengal, India.
Gopal ChakrabartiDr. B.C. Guha Centre for Genetic Engineering, University of Calcutta, Ballygunge Circular Road, Kolkata 700019, West Bengal, India.
Rajagopal ChattopadhyayaDepartment of Biochemistry, Bose Institute, P-1/12, CIT Scheme VII M, Kolkata 700054, West Bengal, India.
Subrata SauDepartment of Biochemistry, Bose Institute, P-1/12, CIT Scheme VII M, Kolkata 700054, West Bengal, India.
Bose Institute · INUniversity of Calcutta · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

FKBP22, an

Indexed as

A82P, a FKBP22/rFKBP22 derivative harboring a Ala to Pro change at position 82 in the helix α3CTD, C-terminal domain of FKBP22FKBP22, a PPIase from Escherichia coliHelix α3I65P, a FKBP22/rFKBP22 variant carrying a Ile to Pro replacement at position 65 in the helix α3Mip, macrophage infectivity potentiatorMutationNTD, N-terminal domain of FKBP22Peptidyl-prolyl cis-trans isomerasePPIase, peptidyl-prolyl cis-trans isomeraserFKBP22, a polyhistidine-tagged FKBP22StabilityStructureTUGE, transverse urea gradient gel electrophoresisV72P, a FKBP22/rFKBP22 variant with a Val to Pro substitution at position 72 in the helix α3

Identifiers

PMID29632827
PMCPMC5889476
OpenAlexW1435710109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.